123 related articles for article (PubMed ID: 479604)
41. Fucose-activated killer (FAK) cells: anomalous killers with augmented cytotoxic activity.
Stanková J; Rola-Pleszczynski M
J Immunol; 1985 Dec; 135(6):3719-28. PubMed ID: 2415584
[TBL] [Abstract][Full Text] [Related]
42. In vitro and in vivo interaction between murine fibrosarcoma cells and natural killer cells.
Laybourn KA; Hiserodt JC; Abruzzo LV; Varani J
Cancer Res; 1986 Jul; 46(7):3407-12. PubMed ID: 2939945
[TBL] [Abstract][Full Text] [Related]
43. Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities.
Stitz L; Baenziger J; Pircher H; Hengartner H; Zinkernagel RM
J Immunol; 1986 Jun; 136(12):4674-80. PubMed ID: 3486908
[TBL] [Abstract][Full Text] [Related]
44. Nonspecific cytotoxicity of vaccinia-induced peritoneal exudates in hamsters is mediated by Thy-1.2 homologue-positive cells distinct from NK cells and macrophages.
Yang H; Tompkins WA
J Immunol; 1983 Nov; 131(5):2545-50. PubMed ID: 6195269
[TBL] [Abstract][Full Text] [Related]
45. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
Burns GF; Triglia T; Werkmeister JA
J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
[TBL] [Abstract][Full Text] [Related]
46. Generation and characterization of purified adherent lymphokine-activated killer cells in mice.
Gunji Y; Vujanovic NL; Hiserodt JC; Herberman RB; Gorelik E
J Immunol; 1989 Mar; 142(5):1748-54. PubMed ID: 2783950
[TBL] [Abstract][Full Text] [Related]
47. Recognition and regulation of progenitor marrow elements by NK cells in the mouse.
O'Brien T; Kendra J; Stephens H; Knight R; Barrett AJ
Immunology; 1983 Aug; 49(4):717-25. PubMed ID: 6192081
[TBL] [Abstract][Full Text] [Related]
48. Assessment of human natural killer and lymphokine-activated killer cell cytotoxicity against Toxoplasma gondii trophozoites and brain cysts.
Dannemann BR; Morris VA; Araujo FG; Remington JS
J Immunol; 1989 Oct; 143(8):2684-91. PubMed ID: 2477453
[TBL] [Abstract][Full Text] [Related]
49. T cell-dependent nonspecific cytotoxicity induced by culture of mouse spleen cells against natural killer-insensitive tumor cells.
Kiyohara T; Tanino T; Egawa K
Jpn J Exp Med; 1982 Aug; 52(4):201-8. PubMed ID: 7176145
[TBL] [Abstract][Full Text] [Related]
50. Natural killer activity in the peritoneal exudates of mice infected with Listeria monocytogenes: characterization of the natural killer cells by using a monoclonal rat anti-murine macrophage antibody (M1/70).
Holmberg LA; Springer TA; Ault KA
J Immunol; 1981 Nov; 127(5):1792-9. PubMed ID: 6795262
[TBL] [Abstract][Full Text] [Related]
51. Reversibility of lymphokine-induced NK-like activity in virus-specific cytotoxic T-lymphocyte clones.
Ronchese F; Collavo D; Zanovello P; Cerundolo V; Biasi G
Immunology; 1985 Feb; 54(2):265-74. PubMed ID: 2578429
[TBL] [Abstract][Full Text] [Related]
52. Rat natural killer cell activity against lymphoid and nonlymphoid tumor cells and normal rat cell lines.
Rees RC; Reynolds CW; Herberman RB
Cancer Res; 1983 Sep; 43(9):4248-52. PubMed ID: 6871862
[TBL] [Abstract][Full Text] [Related]
53. Immunologic control of a retrovirus-associated murine adenocarcinoma. VIII. Corynebacterium parvum-activated natural killer cells as potent antibody-dependent cell-mediated cytotoxicity effectors.
Weinhold KJ; Bolognesi DP; Matthews TJ
J Natl Cancer Inst; 1985 Oct; 75(4):717-24. PubMed ID: 3862904
[TBL] [Abstract][Full Text] [Related]
54. Degradation of specificity in cytolytic T lymphocyte clones. The separate YAC-1-type (NK-like) and P815-type broad specificity killing patterns are both restricted to the larger cells within a clone but may be expressed independently in clones from different mouse strains.
Shortman K; Wilson A
J Immunol; 1986 Aug; 137(3):798-804. PubMed ID: 2424983
[TBL] [Abstract][Full Text] [Related]
55. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.
Bukowski JF; Welsh RM
J Immunol; 1985 Nov; 135(5):3537-41. PubMed ID: 2413125
[TBL] [Abstract][Full Text] [Related]
56. Studies on the activation of mouse bone marrow-derived macrophages by the macrophage cytotoxicity factor (MCF).
Meerpohl HG; Lohmann-Matthes ML; Fischer H
Eur J Immunol; 1976 Mar; 6(3):213-7. PubMed ID: 1086777
[TBL] [Abstract][Full Text] [Related]
57. The beige mutation in the mouse. II. Selectivity of the natural killer (NK) cell defect.
Roder JC; Lohmann-Matthes ML; Domzig W; Wigzell H
J Immunol; 1979 Nov; 123(5):2174-81. PubMed ID: 158612
[No Abstract] [Full Text] [Related]
58. Modulation of natural killing by tumor promoters: the regulatory influence of adherent cells varies with the type of target cell.
Kabelitz D
Immunobiology; 1985 May; 169(4):436-46. PubMed ID: 2408998
[TBL] [Abstract][Full Text] [Related]
59. Functional and phenotypic characteristics of bovine natural cytotoxic cells.
Bielefeldt Ohmann H; Davis WC; Babiuk LA
Immunobiology; 1985 Jul; 169(5):503-19. PubMed ID: 2412953
[TBL] [Abstract][Full Text] [Related]
60. Natural cytotoxicity of mouse monocytes and macrophages.
Tagliabue A; Mantovani A; Kilgallen M; Herberman RB; McCoy JL
J Immunol; 1979 Jun; 122(6):2363-70. PubMed ID: 221585
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
